ArticleBMC infectious diseases2023

Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR].

Liang Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.